American Association of Cancer Research (AACR)

Join us at Booth 4217 and discover cutting-edge solutions for cancer research at AACR 2026!

Molecular Devices is proud to exhibit as part of a combined Danaher booth. Together, we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology.

We’re excited to showcase several of our latest innovations designed to accelerate breakthroughs in oncology.

• ImageXpress® HCS.ai High-Content Screening System with IN Carta® Image Analysis Software – Designed for oncology research workflows, this platform combines high-resolution, multi-modal imaging with AI-powered analysis to generate quantitative insight from complex 2D and 3D cancer models. Supporting applications from high-throughput drug screening to detailed phenotypic characterization of tumor cells and organoids, AI-assisted acquisition workflows and deep learning-based analysis accelerate the path from image to insight while minimizing user variability. This integrated approach simplifies data interpretation at scale, enabling reproducible results and confident decision-making in cancer biology and therapeutic development.
• SpectraMax® i3x Multi-Mode Microplate Reader – Designed for translational cancer research workflows, the SpectraMax i3x reader combines multi‑mode plate reading with optional MiniMax™ Imaging Cytometer under a single-server SoftMax® Pro GxP software environment, enabling validated cell counting and imaging with complete audit trails for the Part 11 compliant user needs. This integrated approach reduces workflow fragmentation while supporting reproducible, compliant cell‑based assays as imaging becomes central to GMP and QC decision‑making.
• CellXpress.ai® Automated Cell Culture System - Standardizing complex cancer models, without slowing discovery. The CellXpress.ai® Automated Cell Culture System helps cancer researchers standardize complex cell culture workflows, from iPSC to 3D tumor and organoid models, using AI driven monitoring and decision making throughout the culture process. Designed to reduce variability and hands on time, the CellXpress.ai system supports consistent outcomes across users and studies, helping you spend less time managing cultures and more time advancing the science that matters.

Stop by to speak with our experts and explore how our technologies can support your research goals.

Attend our poster presentation and learn more:

Title: Automated culture and AI-enabled image analysis of compound responses in patient-derived colorectal cancer organoids
Presenter: Oksana Sirenko, PhD
Date & Time: Tuesday, April 21st, 2:00pm-5:00pm

Featured Products